D
BioPower Operations Corporation BOPO
$0.0001 $0.000.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
D
Sell 3/14/2023Downgrade
BioPower Operations Corporation (BOPO) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell 2/23/2023Upgraded
BioPower Operations Corporation (BOPO) was upgraded to D from D- on 2/23/2023 due to an increase in the valuation index.
D
Sell 2/8/2023Downgrade
BioPower Operations Corporation (BOPO) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index, volatility index and efficiency index. Net income declined 1,760.31% from -$13.1 to -$243.7, and total capital declined 65.19% from -$1.76M to -$2.91M.
D
Sell 7/18/2022Upgraded
BioPower Operations Corporation (BOPO) was upgraded to D from D- on 7/18/2022 due to a noticeable increase in the growth index, efficiency index and volatility index. Operating cash flow increased 401.6% from -$87.5 to $263.9, total revenue increased 23.35% from $200 to $246.7, and total capital increased 11.86% from -$2M to -$1.76M.
D
Sell 9/20/2021Downgrade
BioPower Operations Corporation (BOPO) was downgraded to D- from D on 9/20/2021 due to a significant decline in the efficiency index, growth index and valuation index. Net income declined 25% from -$32.4 to -$40.5, earnings per share declined from -$0.0008 to -$0.0009, and total capital declined 2.04% from -$1.98M to -$2.02M.
D
Sell 8/9/2017Downgrade
BioPower Operations Corporation (BOPO) was downgraded to D from D+ on 8/9/2017 due to a decline in the total return index and volatility index.
D
Sell 7/25/2017Upgraded
BioPower Operations Corporation (BOPO) was upgraded to D+ from D on 7/25/2017 due to an increase in the total return index.
D
Sell 7/10/2017Downgrade
BioPower Operations Corporation (BOPO) was downgraded to D from D+ on 7/10/2017 due to a decline in the volatility index and total return index.
D
Sell 6/7/2017Upgraded
BioPower Operations Corporation (BOPO) was upgraded to D+ from D on 6/7/2017 due to an increase in the volatility index and valuation index.
D
Sell 5/23/2017Downgrade
BioPower Operations Corporation (BOPO) was downgraded to D from D+ on 5/23/2017 due to a decline in the volatility index.
D
Sell 4/3/2017Upgraded
BioPower Operations Corporation (BOPO) was upgraded to D+ from D on 4/3/2017 due to an increase in the volatility index.
D
Sell 12/27/2016Downgrade
BioPower Operations Corporation (BOPO) was downgraded to D from D+ on 12/27/2016 due to a major decline in the total return index and volatility index.
D
Sell 11/18/2016Downgrade
BioPower Operations Corporation (BOPO) was downgraded to D+ from C- on 11/18/2016 due to a noticeable decline in the growth index, volatility index and total return index. Earnings per share declined from -$0.0068 to -$0.0097, and total revenue declined 30.38% from $271.2 to $188.8.
C
Hold 7/21/2016Upgraded
BioPower Operations Corporation (BOPO) was upgraded to C- from D+ on 7/21/2016 due to a noticeable increase in the growth index, total return index and solvency index. Debt to equity declined from -0.11 to -0.73, EBIT increased 68.86% from -$986.7 to -$307.3, and earnings per share increased from -$0.0241 to -$0.01.
D
Sell 6/13/2016Upgraded
BioPower Operations Corporation (BOPO) was upgraded to D+ from D on 6/13/2016 due to a noticeable increase in the total return index and volatility index.
D
Sell 5/27/2016Downgrade
BioPower Operations Corporation (BOPO) was downgraded to D from D+ on 5/27/2016 due to a decline in the volatility index.
D
Sell 5/12/2016Upgraded
BioPower Operations Corporation (BOPO) was upgraded to D+ from D on 5/12/2016 due to an increase in the volatility index.
D
Sell 4/27/2016Downgrade
BioPower Operations Corporation (BOPO) was downgraded to D from D+ on 4/27/2016 due to a decline in the volatility index.
D
Sell 4/21/2016Downgrade
BioPower Operations Corporation (BOPO) was downgraded to D+ from C- on 4/21/2016 due to a major decline in the growth index and total return index. EBIT declined 134.26% from -$421.2 to -$986.7, and earnings per share declined from -$0.0138 to -$0.0241.
C
Hold 3/16/2016Upgraded
BioPower Operations Corporation (BOPO) was upgraded to C- from D on 3/16/2016 due to a substantial increase in the growth index, total return index and volatility index. Operating cash flow increased 69.57% from -$138.7 to -$42.2, EBIT increased 21.56% from -$537 to -$421.2, and earnings per share increased from -$0.0148 to -$0.0138.
D
Sell 3/11/2016Downgrade
BioPower Operations Corporation (BOPO) was downgraded to D from C on 3/11/2016 due to a significant decline in the volatility index and total return index.
C
Hold 1/12/2016Upgraded
BioPower Operations Corporation (BOPO) was upgraded to C from C- on 1/12/2016 due to a large increase in the volatility index.
C
Hold 12/28/2015Downgrade
BioPower Operations Corporation (BOPO) was downgraded to C- from C on 12/28/2015 due to a large decline in the volatility index.
C
Hold 12/2/2015Upgraded
BioPower Operations Corporation (BOPO) was upgraded to C from C- on 12/2/2015 due to a large increase in the volatility index and valuation index.
C
Hold 10/23/2015Downgrade
BioPower Operations Corporation (BOPO) was downgraded to C- from C on 10/23/2015 due to a major decline in the volatility index and solvency index.
C
Hold 3/30/2015Upgraded
BioPower Operations Corporation (BOPO) was upgraded to C from C- on 3/30/2015 due to an increase in the total return index, growth index and volatility index.
C
Hold 3/13/2015Downgrade
BioPower Operations Corporation (BOPO) was downgraded to C- from C on 3/13/2015 due to a large decline in the growth index, solvency index and valuation index.
C
Hold 9/29/2014Upgraded
BioPower Operations Corporation (BOPO) was upgraded to C from C- on 9/29/2014 due to a noticeable increase in the efficiency index, valuation index and total return index. Total capital increased 11.85% from -$1.48M to -$1.66M.
Weiss Ratings